The conference secretariat for the 12th annual Skin Spectrum Summit invites Canadian medical researchers and students to submit poster presentations for display at the upcoming Summit on Oct. 31, 2026 in Toronto. The Summit’s scientific committee will peer-review all submissions. Space is limited, so we encourage early submission. To submit your presentation for consideration, please provide the following: 1. A structured abstract (300 words maximum) including: - Backgroun

Changes to white blood cell counts have been linked to different survival outcomes in melanoma patients

Image courtesy Dr. U Hair and Skin Clinic Three severe scalp conditions usually diagnosed separately may represent a single clinical syndrome, according to a small case series that could help physicians identify extensive disease earlier. The study, published in Clinical, Cosmetic and Investigational Dermatology, linked acne keloidalis nuchae (AKN), dissecting cellulitis of the scalp (DCS), and secondary cutis verticis gyrata, or CVG. AKN produces inflammatory papules and thi

Photo by Eisfelder via Wikimedia Commons New research has documented a significant impact of severe atopic dermatitis (AD) on a child’s height, and that dupilumab treatment can help improve growth. The study, published in the Journal of the American Academy of Dermatology, investigated the effect of a medication commonly used to treat AD on growth and bone biomarkers in 123 children aged six to 11 years with severe eczema. Researchers found that children who had severe AD and

Conversation cards may be an effective way to support patient-centred HS care

Dermatologists use the term postinflammatory hyperpigmentation (PIH) to describe darkened skin that remains after an inflammatory disorder has subsided. But the inflammation may not always be over, and a JAMA Dermatology viewpoint argues that the term “postinflammatory” may obscure persistent disease activity, particularly in patients with darker skin tones. Dr. Jerry Tan The authors point out that hyperpigmentation can coexist with ongoing inflammation, particularly in chron

BMAL1 (green) and YAP1 (red) in the adult (top) and aged (bottom) epidermis. Cell nuclei appear in blue. Image courtesy the Institute for Research in Biomedicine, Barcelona A new study describes a molecular mechanism that helps explain the drivers of persistent low-grade inflammation that impairs skin regeneration as humans age. Findings show that during aging, two proteins, BMAL1 and YAP, change how they work together and increase the activity of inflammatory genes in the ep

Zasocitinib is effective in improving skin clearance for PsO patients in hard-to-treat areas with once-daily treatment